AMI Organics Ltd.

1124.65 -5.75 ▼-0.5%

28 February 2024, 04:01:00 PM
Volume: 6,840

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.amiorganics.com
Market Cap 4,147.77 Cr.
Enterprise Value(EV) 4,165.83 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 11.32 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 99.35 Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 175.79 Trailing Twelve Months Ending 2023-12
Price to Book Value 6.40 Calculated using Price: 1,124.65
Dividend Yield 0.27 Period Ending 2023-03
No. of Shares Subscribed 3.69 Cr. 36,880,562 Shares
FaceValue 10
About AMI Organics Ltd.
The company is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

AMI Organics Ltd. Delivery

Delivered Qty
Traded Qty

AMI Organics Ltd. Performance

1 Day
-0.51%
1 Week
+2.15%
1 Month
+3.57%
3 Month
+1.38%
6 Month
-15.27%
1 Year
+23.96%
2 Year
+32.39%
5 Year
10 Year

AMI Organics Ltd. Fundamental Ratios

8 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 46.43 36.44 39.03 34.64 29.78 40.51 21.07 14.92
Return on Capital Employed (%) 35.54 35.91 38.24 34.33 27.09 33.43 23.85 20.45
Return on Assets (%) 13.87 12.04 13.99 12.64 12.34 16.74 13.42 11.68

AMI Organics Ltd. Balance Sheet

Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 27 39 58 82 112 167 522 594 631
Non Curr. Liab. 15 15 33 25 25 80 7 10 54
Curr. Liab. 49 55 65 106 95 166 129 163 269
Minority Int. 15
Equity & Liab. 91 109 155 213 232 413 659 767 968
Non Curr. Assets 25 42 66 85 105 191 229 297 397
Curr. Assets 66 66 87 124 121 216 430 470 571
Misc. Exp. not W/O 0 0 2 4 6 6
Total Assets 91 109 155 213 232 413 659 767 968

AMI Organics Ltd. Profit and Loss

Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 154 160 188 239 240 341 520 617 668
Other Income 3 0 3 0 3 1 3 4 6
Total Income 157 160 191 239 242 342 523 621 673
Total Expenditure -136 -137 -158 -196 -199 -260 -415 -494 -550
PBIDT 21 23 33 42 44 82 108 127 123
Interest -3 -3 -3 -5 -6 -6 -6 -2 -4
Depreciation -1 -1 -2 -3 -4 -4 -10 -12 -14
Taxation -5 -7 -10 -12 -7 -18 -20 -29 -28
Exceptional Items -32
PAT 13 12 19 23 27 54 72 83 45
Minority Interest -3
Share Associate
Other Related Items 0
Consolidated Net Profit 13 12 19 23 27 54 72 83 42
Adjusted EPS 4 4 6 7 9 6 20 23 11

AMI Organics Ltd. Cash Flow

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 10 29 8 15 27 28 -12 66
Cash Fr. Inv. -14 -19 -25 -21 -24 -101 -121 -33
Cash Fr. Finan. 4 -7 15 6 0 72 140 -12
Net Change 0 3 -2 0 3 -1 8 20
Cash & Cash Eqvt 0 3 1 0 4 3 10 31

AMI Organics Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 41.05 41.05 41.05 39.41 39.41 39.41 39.41 38.93 39.91
Public 58.95 58.95 58.95 60.59 60.59 60.59 60.59 61.07 60.09
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

AMI Organics Ltd. Announcements

Fri, 23 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform that the Companys Officials will attend Investec India Promoter & Founder Conference 2024 on February 28 2024 as per the details attached.
Fri, 16 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We hereby enclose the transcript of the Earnings Conference Call held on February 12 2024.
Tue, 13 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of the Unaudited Financial Results for the third quarter and nine months ended December 31 2023 is attached.

AMI Organics Ltd. Technical Scans

Tue, 27 Feb 2024
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High
Close Above Last Week High Close Above Last Week High
Closing Above Previous High for 2 Days Closing Above Previous High for 2 Days
Making Higher Highs for 2 Days Making Higher Highs for 2 Days

AMI Organics Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 379,622.78 1,570.50 -0.7%
Cipla Ltd. 120,180.38 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. 107,577.80 6,420.70 -0.4%
Zydus Lifesciences Ltd. 95,400.24 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. 95,163.88 6,371.85 -3.7%
Divi's Laboratories Ltd. 93,921.46 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. 88,823.31 2,598.00 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.62 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 32.41 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.58 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 120.56 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 67.91 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.45 2,598.00 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.08 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 4.64 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.09 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 7.21 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.42 2,598.00 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,598.00 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,598.00 -1.0%

AMI Organics Ltd. FAQ's

What is AMI Organics share price?

Can I buy AMI Organics shares now?

What is the Dividend Yield of AMI Organics?

What is the Market Cap of AMI Organics?

What are the key metrics to analyse AMI Organics?

What is the 52 Week High and Low of AMI Organics?

What is the trend of AMI Organics share price?